JiangXi Tianxin Pharmaceutical Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Xiaobing Yua
Chief executive officer
CN¥1.3m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.2yrs |
| CEO ownership | n/a |
| Management average tenure | 4.2yrs |
| Board average tenure | 5.7yrs |
Recent management updates
No updates
Recent updates
CEO
Xiaobing Yua (43 yo)
1.2yrs
Tenure
CN¥1,345,300
Compensation
Mr. Xiaobing Yua is MD & Director of JiangXi Tianxin Pharmaceutical Co., Ltd. from November 16, 2023. He was Deputy General Manager of JiangXi Tianxin Pharmaceutical Co., Ltd.from November 20, 2020 to Nov...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Director | 1.2yrs | CN¥1.35m | no data | |
| Financial Director | 7.2yrs | CN¥847.30k | no data | |
| Deputy GM & Director | 1.2yrs | CN¥997.60k | no data | |
| Board Secretary | 4.2yrs | CN¥1.06m | no data | |
| Deputy General Manager | 4.2yrs | CN¥266.70k | no data | |
| Deputy General Manager | 4.2yrs | CN¥1.25m | no data |
4.2yrs
Average Tenure
43yo
Average Age
Experienced Management: 603235's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Director | 1.2yrs | CN¥1.35m | no data | |
| Deputy GM & Director | 1.2yrs | CN¥997.60k | no data | |
| Chairman of the Supervisory Board | 7.2yrs | no data | no data | |
| Chairman of the Board | 7.2yrs | CN¥2.11m | 46.69% CN¥ 5.1b | |
| Director | 7.2yrs | CN¥35.90k | 13.56% CN¥ 1.5b | |
| Director | 7.2yrs | CN¥1.62m | 13.03% CN¥ 1.4b | |
| Independent Director | 4.2yrs | CN¥120.00k | no data | |
| Independent Director | 4.2yrs | CN¥120.00k | no data | |
| Supervisor | 7.2yrs | no data | no data | |
| Supervisor | 4.2yrs | no data | no data |
5.7yrs
Average Tenure
51yo
Average Age
Experienced Board: 603235's board of directors are considered experienced (5.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/04 08:28 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
JiangXi Tianxin Pharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|